ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
57.20
-2.07 (-3.49%)
Sep 12, 2025, 4:00 PM EDT - Market closed
BIB Holdings Information
BIB is an equity ETF with a total of 262 individual holdings. The top holdings are NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG stock at 31.60%, NASDAQ BIO INDEX SWAP BNP PARIBAS at 25.85%, NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA at 25.61%, NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA at 20.60%, and NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE at 16.54%.
Total Holdings
262
Top 10 Percentage
153.08%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
57.50M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 31.60% |
2 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 25.85% |
3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 25.61% |
4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 20.60% |
5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 16.54% |
6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 16.50% |
7 | GILD | Gilead Sciences, Inc. | 4.53% |
8 | AMGN | Amgen Inc. | 4.21% |
9 | VRTX | Vertex Pharmaceuticals Incorporated | 3.91% |
10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.73% |
11 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.36% |
12 | AZN | AstraZeneca PLC | 2.98% |
13 | INSM | Insmed Incorporated | 1.69% |
14 | ARGX | argenx SE | 1.51% |
15 | BIIB | Biogen Inc. | 1.35% |
16 | UTHR | United Therapeutics Corporation | 1.16% |
17 | INCY | Incyte Corporation | 1.02% |
18 | RPRX | Royalty Pharma plc | 0.97% |
19 | ILMN | Illumina, Inc. | 0.95% |
20 | TEM | Tempus AI, Inc. | 0.92% |
21 | MEDP | Medpace Holdings, Inc. | 0.89% |
22 | SMMT | Summit Therapeutics Inc. | 0.89% |
23 | NBIX | Neurocrine Biosciences, Inc. | 0.89% |
24 | ONC | BeOne Medicines AG | 0.85% |
25 | SNY | Sanofi | 0.84% |
As of Sep 12, 2025